Trial Profile
Clinical Trials Insight: 700028131
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2007
Price :
$35
*
At a glance
- Drugs 1-alpha-hydroxyvitamin-D5 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Marillion Pharmaceuticals
- 05 Nov 2007 New trial record.